DVLP (Golden Developing Solutions) Days Payable: 232.38 (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Golden Developing Solutions Days Payable?

Golden Developing Solutions DVLP -90.00% Days Payable is 232.38 as of Jun. 2023.

Golden Developing Solutions's average Accounts Payable for the three months ended in Jun. 2023 was $1.15 Mil. Golden Developing Solutions's Cost of Goods Sold for the three months ended in Jun. 2023 was $0.45 Mil. Hence, Golden Developing Solutions's Days Payable for the three months ended in Jun. 2023 was 232.38.

The historical rank and industry rank for Golden Developing Solutions's Days Payable or its related term are showing as below:

DVLP's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.38
* Ranked among companies with meaningful Days Payable only.

Golden Developing Solutions's Days Payable increased from Mar. 2022 (0.00) to Jun. 2023 (232.38). It may suggest that Golden Developing Solutions delayed paying its suppliers.

Golden Developing Solutions Days Payable Historical Data

* Premium members only.

The historical data trend for Golden Developing Solutions's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Golden Developing Solutions Days Payable Chart

Golden Developing Solutions Annual Data
Trend Dec21 Dec22
Days Payable
0.00 0.00

Golden Developing Solutions Quarterly Data
Mar19 Jun19 Sep19 Mar20 Jun20 Sep20 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 396.73 232.38

DVLP vs CSTF, BLMS, BBBT: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Golden Developing Solutions's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Golden Developing Solutions Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Golden Developing Solutions's Days Payable distribution charts can be found below:

* The bar in red indicates where Golden Developing Solutions's Days Payable falls into.


Golden Developing Solutions Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Golden Developing Solutions's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

Days Payable (A: Dec. 2022 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2021 ) + Accounts Payable (A: Dec. 2022 )) / count ) / Cost of Goods Sold (A: Dec. 2022 )*Days in Period
=( (0.201 + 0.167) / 2 ) / 0*365
=0.184 / 0*365
=N/A

Golden Developing Solutions's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

Days Payable (Q: Jun. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Mar. 2023 ) + Accounts Payable (Q: Jun. 2023 )) / count ) / Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=( (1.146 + 0) / 1 ) / 0.45*365 / 4
=1.146 / 0.45*365 / 4
=232.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 232.38 mean?
Golden Developing Solutions (DVLP) has a Days Payable of 232.38 as of Jun. 2023. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Golden Developing Solutions and its competitors.
Is Golden Developing Solutions' Days Payable too high?
Golden Developing Solutions' current Days Payable is 232.38. The Drug Manufacturers industry median Days Payable is 90.38. Golden Developing Solutions' value of 232.38 is 157.1% above this industry median.
How does Golden Developing Solutions' Days Payable compare to CSTF and BLMS?
Golden Developing Solutions' Days Payable of 232.38 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.38. Golden Developing Solutions' value of 232.38 is 157.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Golden Developing Solutions's current Days Payable of 232.38 is 157.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Golden Developing Solutions and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Golden Developing Solutions's current Days Payable is 232.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Golden Developing Solutions stock overvalued right now?
Golden Developing Solutions (DVLP) has a current Days Payable of 232.38. The current Days Payable is 232.38 and 157.1% above the Drug Manufacturers industry median of 90.38. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Golden Developing Solutions (DVLP), the current Days Payable is 232.38 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Golden Developing Solutions Business Description

Address PO Box 460573, Fort Lauderdale, FL, USA, 33346
Golden Developing Solutions Inc is a development-stage company providing business services and/or products supporting Health, Wellness, and Technology. The company is also focused on acquisitions of synergistic companies.